ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
node1 |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
prov:Person |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
owl:sameAs |
https://semopenalex.org/author/A5040838367 |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
foaf:familyName |
Zhou |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
foaf:givenName |
Tong-Chong |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |
foaf:name |
Tong-Chong Zhou |
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
dcterms:creator |
ripekg:author/RIPEAUECD5CEC2E2E1904CTong-Chong Zhou |